Kazia Therapeutics
KZIA
9 hedge funds and large institutions have $121K invested in Kazia Therapeutics in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 4 closing their positions.
4.62% less ownership
Funds ownership: 7.39% → 2.76% (-4.6%)
10% less funds holding
Funds holding: 10 → 9 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
79% less capital invested
Capital invested by funds: $569K → $121K (-$448K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GI
GAMMA Investing
Foster City,
California
|
+$1.57K |
| 2 |
AAP
Arax Advisory Partners
Denver,
Colorado
|
+$1.18K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$6 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
MAI Capital Management
Independence,
Ohio
|
-$160K |
| 2 |
Morgan Stanley
New York
|
-$41.5K |
| 3 |
JP Morgan Chase
New York
|
-$12.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.49K |
| 5 |
Citigroup
New York
|
-$1.27K |
KZIA Hedge Fund Activity: Q1 2025 in Review
9 of the 7,473 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q1 2025, worth a combined $121K — down 79% from $569K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of KZIA and 3 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 0 added.
The largest buyer was GAMMA Investing, opening a new position worth an estimated $1.57K. The largest seller was MAI Capital Management, cutting an estimated $160K.
- 9 institutional investors held Kazia Therapeutics (KZIA) as of Q1 2025, down from 10 in Q4 2024.
- Funds reported $121K of Kazia Therapeutics stock for Q1 2025, down 79% quarter-over-quarter.
- 3 funds opened new Kazia Therapeutics positions in Q1 2025 and 4 closed out, a net change of -1 holder.
- The largest Kazia Therapeutics buyer in Q1 2025 was GAMMA Investing, an estimated $1.57K added.
- The largest Kazia Therapeutics seller in Q1 2025 was MAI Capital Management, an estimated $160K sold.
Based on aggregated 13F filings for Q1 2025.